Liarozole
{[allProObj[0].p_purity_real_show]}
货号：A161291
同义名：
R75251
Liarozole (R75251; R85246)是一种咪唑衍生物，作为口服有效的维甲酸 (RA) 代谢阻断剂 (RAMBA)，它抑制维甲酸依赖的细胞色素P450 (CYP26) 4-羟基化，IC50 为7 μM，从而增加组织维甲酸水平，并具有抗肿瘤 特性。
Liarozole 化学结构
Liarozole 3D分子结构
规格
价格
会员价
库存
数量
{[ item.pr_size ]}
{[ getRatePrice(item.pr_rmb, 1,1) ]}
{[ getRatePrice(item.pr_rmb_sale, 1,1) ]}
{[ suihuo_tips(item.pr_am, item.pr_size) ]}
{[ getRatePrice(item.pr_rmb, 1,1) ]}
{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]}
{[ suihuo_tips(item.pr_am, item.pr_size) ]}
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]}
{[ getRatePrice(item.pr_rmb_sale, 1,1) ]}
{[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]}
{[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]}
现货
咨询
-
+
Liarozole 纯度/质量文件 产品仅供科研
货号：A161291
标准纯度：
{[allProObj[0].p_purity_real_show]}
产品说明书
全球学术期刊中引用的产品
• Nat. Biomed. Eng. , 2024, 8, 1412-1424. Ambeed. A538667 ,
A631746
]
• JMC , 2024. Ambeed. A356070
]
• BMC Cancer , 2024, 24(1): 1415. Ambeed. A209020
]
• J. Am. Soc. Mass Spectrom. , 2024, 35(12): 3192-3202. Ambeed. A961334 ,
A292945 ,
A230770 ,
A300620 ,
A1114580 ,
A1159765 ,
A206238
]
• PloS One , 2024, 19(11): e0308060. Ambeed. 更多 >
Liarozole 质控信息
Liarozole 生物活性
描述
Liarozole is an imidazole derivative and metabolic blocker of retinoic acid with oral activity. Liarozole inhibits CYP26-dependent 4-hydroxylation of retinoic acid with an IC50 value of 7 μM, leading to an increase in tissue levels of retinoic acid. Liarozole possesses antitumour properties[1] [2] [3] [3] [4]
Liarozole 动物研究
Animal study
At a dose of 5-20 mg/kg administered orally for 3 days, Liarozole reversed vaginal keratosis induced by estrogen stimulation[5] [6]
Liarozole 参考文献
[1] Kuijpers AL, et al. The effects of oral liarozole on epidermal proliferation and differentiation in severe plaque psoriasis are comparable with those of acitretin. Br J Dermatol. 1998;139(3):380-389.
[2] Lucker GP, et al. Oral treatment of ichthyosis by the cytochrome P-450 inhibitor liarozole. Br J Dermatol. 1997;136(1):71-75.
[3] Wouters W, et al. Effects of liarozole, a new antitumoral compound, on retinoic acid-induced inhibition of cell growth and on retinoic acid metabolism in MCF-7 human breast cancer cells. Cancer Res. 1992;52(10):2841-2846.
[4] Pignatello MA, et al. Liarozole markedly increases all trans-retinoic acid toxicity in mouse limb bud cell cultures: a model to explain the potency of the aromatic retinoid (E)-4-[2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthylenyl)-1-propenyl] benzo
[5] Van Wauwe J, et al. Liarozole, an inhibitor of retinoic acid metabolism, exerts retinoid-mimetic effects in vivo. J Pharmacol Exp Ther. 1992;261(2):773-779.
[6] Stearns ME, et al. Liarozole and 13-cis-retinoic acid anti-prostatic tumor activity [published correction appears in Cancer Res 1993 Dec 1;53(23):5831]. Cancer Res. 1993;53(13):3073-3077.
展开
Liarozole 实验方案
计算器
摩尔计算器
总药量计算器
工作液计算器
存储液制备
1mg
5mg
10mg
1 mM
5 mM
10 mM
3.24mL
0.65mL
0.32mL
16.19mL
3.24mL
1.62mL
32.39mL
6.48mL
3.24mL
Liarozole 技术信息
搜索
